125 results on '"Naik, Snehal"'
Search Results
2. Supplementary Data from Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant β-Catenin Activation in Colon Cancer
3. CCR Translation for the Article from Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant β-Catenin Activation in Colon Cancer
4. Correction to: Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases
5. Phase I Trial, Quotient Code: QSC205947
6. Virtual Think-Tank on AAV vectors
7. The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease
8. P209 Etrasimod improves quality of life in adults with moderate-to-severe ulcerative colitis
9. 987 EFFICACY AND SAFETY OF THE ORAL SELECTIVE SPHINGOSINE-1-PHOSPHATE-1 RECEPTOR MODULATOR VTX002 IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 TRIAL
10. Real-Time Imaging of β-Catenin Dynamics in Cells and Living Mice
11. S714 Etrasimod Improves Quality of Life in Adults With Moderate-to-Severe Ulcerative Colitis: Results From the Phase 2 OASIS Trial and Open-Label Extension
12. Challenges and Opportunities in IBD Clinical Trial Design
13. 43073 Pharmacokinetics, Safety and Pharmacodynamics of VTX2735, A Potent and Selective NLRP3 Inhibitor, In Healthy Adult Volunteers
14. The functional repertoire of rabbit antibodies and antibody discovery via next-generation sequencing
15. Real-time imaging of [beta]-catenin dynamics in cells and living mice
16. Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
17. Imaging Cellular Networks and Protein-Protein Interactions In Vivo
18. Detection of Protein-Protein Interactions in Live Cells and Animals with Split Firefly Luciferase Protein Fragment Complementation
19. PPARγ activation redirects macrophage cholesterol from fecal excretion to adipose tissue uptake in mice via SR-BI
20. S0768 Early and Durable Symptom Control in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Etrasimod (APD334) in the Phase 2 OASIS Trial and Open Label Extension
21. Su1926 FECAL CALPROTECTIN AND C-REACTIVE PROTEIN LEVELS ARE CORRELATED WITH LONG TERM CLINICAL AND ENDOSCOPIC OUTCOMES: ANALYSIS OF THE OASIS OPEN LABEL EXTENSION TRIAL OF ETRASIMOD FOR ULCERATIVE COLITIS
22. Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis
23. 764 Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study
24. 1006 – Histologic Remission and Mucosal Healing in a Randomized, Placebo-Controlled, Phase 2 Study of Etrasimod in Patients with Moderately to Severely Active Ulcerative Colitis
25. Tu1745 – Correlation of Fecal Calprotectin and C-Reactive Protein Concentrations with Clinical Outcomes and Endoscopic Disease Activity in Patients with Ulcerative Colitis Receiving Induction Therapy with Etrasimod
26. Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease
27. A Randomized, Double-Blind, Placebo-Controlled Trial of a Selective, Oral Sphingosine 1-Phosphate (S1P) Receptor Modulator, Etrasimod (APD334), in Moderate to Severe Ulcerative Colitis (UC): Results From the OASIS Study: ACG Auxiliary Award (Member)
28. 233 - Low Infliximab Levels and Anti-Infliximab Antibodies Increase the Risk of Loss of Response to Infliximab in Pediatric IBD, a Prospective Pediatric Study
29. Mo1857 - Vedolizumab Levels During Induction are Associated with Long-Term Clinical and Endoscopic Remission in Patients with Inflammatory Bowel Disease
30. Vedolizumab Levels During Induction Are Associated With Remission in Patients With Inflammatory Bowel Diseases: 2017 Category Award (IBD): 2017 Presidential Poster Award
31. Long-Term Peritoneal Dialysis May Result in Vascular Changes Within the Peritoneal Cavity, Leading to Reduced Efficacy of Intravenous Antibiotics in Treatment of Bacterial Peritonitis
32. Torsion of a Wandering Spleen With Splenic and Gastric Varices Presenting as Abdominal Pain
33. Higher Vedolizumab Trough Levels Associated with Remission in Inflammatory Bowel Disease (IBD) During Maintenance Therapy
34. Higher Vedolizumab Levels are Associated with Deep Remission in Patients with Crohn's Disease and Ulcerative Colitis on Maintenance Therapy with Vedolizumab
35. Detection of adalimumab and antibodies to adalimumab using a homogeneous mobility shift assay
36. Association of Vedolizumab Concentrations Using Anser: Mobility Shift Assay and Clinical Response in IBD Patients in Clinical Practice
37. Testing Serum Infliximab and Serum Antibodies to Infliximab with a Drug Tolerant Assay Has a Significant Effect on Clinical Decision Making in the Treatment of Patients with Inflammatory Bowel Diseases
38. Analysis of Serum Adalimumab-Treated Patients Using the Anser ADA Homogenous Mobility Shift Assay
39. An Automated Agricultural Robot
40. RNA Interference Screen Identifies VEGFR1 as Potentially Synthetic Lethal to Aberrant Wnt/β-catenin Activation in Colon Cancer
41. Sa1906 - Higher Vedolizumab Levels are Associated with Deep Remission in Patients with Crohn's Disease and Ulcerative Colitis on Maintenance Therapy with Vedolizumab
42. Sa1891 - Higher Vedolizumab Trough Levels Associated with Remission in Inflammatory Bowel Disease (IBD) During Maintenance Therapy
43. Pseudo-Static Stability Analysis of a Prototype Seawall
44. Establishment of paternal allele-specific DNA methylation at the imprinted mouseGtl2locus
45. Peroxisome Proliferator-Activated Receptor-α Activation Promotes Macrophage Reverse Cholesterol Transport Through a Liver X Receptor–Dependent Pathway
46. Dual-Color Click Beetle Luciferase Heteroprotein Fragment Complementation Assays
47. Alzheimer's disease target selection
48. P1-140: Common pathways and cellular processes as revealed by computational analysis of expression patterns from Tg4510 mice and human Alzheimer brains
49. Abstract LB-137: Reversibility of click beetle luciferase heteroprotein fragment complementation systems for imaging cancer pathways in live cells
50. Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant β-Catenin Activation in Colon Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.